Li Xiaohua, Thompson David, Kumar Brajesh, DeMartino George N
From the Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390.
From the Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390
J Biol Chem. 2014 Jun 20;289(25):17392-405. doi: 10.1074/jbc.M114.561183. Epub 2014 Apr 25.
We investigated molecular features and cellular roles of PI31 (PSMF1) on regulation of proteasome function. PI31 has a C-terminal HbYX (where Hb is a hydrophobic amino acid, Y is tyrosine, and X is any amino acid) motif characteristic of several proteasome activators. Peptides corresponding to the PI31 C terminus also bind to and activate the 20 S proteasome in an HbYX-dependent manner, but intact PI31protein inhibits in vitro 20 S activity. Binding to and inhibition of the proteasome by PI31 are conferred by the HbYX-containing proline-rich C-terminal domain but do not require HbYX residues. Thus, multiple regions of PI31 bind independently to the proteasome and collectively determine effects on activity. PI31 blocks the ATP-dependent in vitro assembly of 26 S proteasome from 20 S proteasome and PA700 subcomplexes but has no effect on in vitro activity of the intact 26 S proteasome. To determine the physiologic significance of these in vitro effects, we assessed multiple aspects of cellular proteasome content and function after altering PI31 levels. We detected no change in overall cellular proteasome content or function when PI31 levels were either increased by moderate ectopic overexpression or decreased by RNA interference (RNAi). We also failed to identify a role of PI31 ADP-ribosylation as a mechanism for regulation of overall 26 S proteasome content and function, as recently proposed. Thus, despite its in vitro effects on various proteasome activities and its structural relationship to established proteasome regulators, cellular roles and mechanisms of PI31 in regulation of proteasome function remain unclear and require future definition.
我们研究了PI31(PSMF1)在蛋白酶体功能调控方面的分子特征和细胞作用。PI31具有C端HbYX(其中Hb为疏水氨基酸,Y为酪氨酸,X为任意氨基酸)基序,这是几种蛋白酶体激活剂的特征。与PI31 C端对应的肽段也以HbYX依赖的方式结合并激活20S蛋白酶体,但完整的PI31蛋白在体外抑制20S活性。PI31与蛋白酶体的结合及抑制作用由含HbYX的富含脯氨酸的C端结构域介导,但不需要HbYX残基。因此,PI31的多个区域独立地与蛋白酶体结合,并共同决定对活性的影响。PI31可阻断20S蛋白酶体和PA700亚复合物在ATP依赖下的体外组装形成26S蛋白酶体,但对完整26S蛋白酶体的体外活性没有影响。为了确定这些体外效应的生理意义,我们在改变PI31水平后评估了细胞蛋白酶体含量和功能的多个方面。当通过适度的异位过表达增加PI31水平或通过RNA干扰(RNAi)降低PI31水平时,我们未检测到细胞蛋白酶体的总体含量或功能发生变化。我们也未能确定PI31 ADP核糖基化作为调节26S蛋白酶体总体含量和功能的机制,这是最近提出的。因此,尽管PI31在体外对各种蛋白酶体活性有影响,且与已确定的蛋白酶体调节剂存在结构关系,但其在蛋白酶体功能调控中的细胞作用和机制仍不清楚,需要未来进一步明确。